Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial

BACKGROUND: Use of kinase inhibitors such as dasatinib and imatinib might increase the risk of opportunistic infections, especially Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections. However, the effect of sorafenib on EBV and CMV infections remains unclear. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xin, Fan, Zhiping, Wang, Yu, Huang, Fen, Xu, Yajing, Sun, Jing, Xu, Na, Deng, Lan, Li, Xudong, Liang, Xinquan, Luo, Xiaodan, Shi, Pengcheng, Liu, Hui, Chen, Yan, Tu, Sanfang, Huang, Xiaojun, Liu, Qifa, Xuan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436457/
https://www.ncbi.nlm.nih.gov/pubmed/36050712
http://dx.doi.org/10.1186/s12916-022-02479-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436457/
https://www.ncbi.nlm.nih.gov/pubmed/36050712
http://dx.doi.org/10.1186/s12916-022-02479-x

Ejemplares similares